Patient characteristics and treatment patterns of patients with locally advanced or metastatic HER2-low breast cancer, a single site descriptive study.
Connor WillisChia Jie TanAnindit ChhibberAlexandre H WatanabeClara LamSandhya MehtaJackie KwongLeah ParkMelissa Pavilack-KirkerXiaoqing XuKristen KelleyDavid D StenehjemPublished in: Breast cancer research and treatment (2024)
A substantial proportion of patients previously classified as HER2-negative have low but detectable HER2 expression and may benefit from novel HER2-directed agents, which have demonstrated clinical benefit in this population post-chemotherapy.
Keyphrases
- locally advanced
- squamous cell carcinoma
- end stage renal disease
- newly diagnosed
- poor prognosis
- rectal cancer
- ejection fraction
- chronic kidney disease
- small cell lung cancer
- prognostic factors
- radiation therapy
- peritoneal dialysis
- case report
- clinical trial
- long non coding rna
- combination therapy
- patient reported outcomes
- binding protein